{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"neutral-lipid-storage-disease","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Neutral lipid storage disease (NLSD) refers to a group of diseases characterized by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: currently cases of NLSD with icthyosis (NLSDI/Dorfman-Chanarin disease; see this term) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy; see this term) can be distinguished.","mondoId":"MONDO:0015611","node":{"canonicalSlug":"neutral-lipid-storage-disease","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Neutral lipid storage disease","originalSourceId":"ORPHA:165","paragraphs":["Neutral lipid storage disease (NLSD) refers to a group of diseases characterized by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: currently cases of NLSD with icthyosis (NLSDI/Dorfman-Chanarin disease; see this term) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy; see this term) can be distinguished."],"rawAttribution":"MONDO:0015611","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:58Z","upstream":"MONDO:0015611","url":"https://rarediseases.info.nih.gov/diseases/3262"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"disorder of phospholipids, sphingolipids and fatty acids biosynthesis","mondoId":"MONDO:0018117","slug":null},{"kind":"parent","label":"lysosomal lipid storage disorder","mondoId":"MONDO:0019245","slug":"lysosomal-lipid-storage-disorder"},{"kind":"child","label":"Dorfman-Chanarin disease","mondoId":"MONDO:0010155","slug":"dorfman-chanarin-disease"},{"kind":"child","label":"neutral lipid storage myopathy","mondoId":"MONDO:0012545","slug":"neutral-lipid-storage-disease-with-myopathy"},{"kind":"child","label":"triglyceride deposit cardiomyovasculopathy","mondoId":"MONDO:0979259","slug":"triglyceride-deposit-cardiomyovasculopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/chanarin-dorfman-syndrome"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3262\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0015611\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0015611</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Neutral lipid storage disease (NLSD) refers to a group of diseases characterized by a deficit in the degradation of cytoplasmic triglycerides and their accumulation in cytoplasmic lipid vacuoles in most tissues of the body. The group is heterogeneous: currently cases of NLSD with icthyosis (NLSDI/Dorfman-Chanarin disease; see this term) and NLSD with myopathy (NLSDM/neutral lipid storage myopathy; see this term) can be distinguished.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/3262\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"neutral-lipid-storage-disease","sourceDocuments":[{"name":"GARD: Neutral lipid storage disease","reviewed":null,"source_release":"2026-10-25T03:38:58Z","url":"https://rarediseases.info.nih.gov/diseases/3262"},{"name":"MONDO: neutral lipid storage disease","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0015611"}],"sourceNote":"","synonyms":["Chanarin-Dorfman syndrome","lipidosis with triglycerid storage disease","lipidosis with triglyceride storage disease"],"takeawayHtml":"","title":"neutral lipid storage disease"},"schemaVersion":1}
